News Details

Next-Gen Test Uses Robotics & AI to Predict Responses to Cancer Drugs

The PARIS Test prescreens a broad panel of cancer drugs in patient-derived live tumor cells and provides actionable results 70% of the time, on average.

SourceMD&M East
Last Updated08/10/2021

Next-Gen Test Uses Robotics & AI to Predict Responses to Cancer Drugs - Image

The PARIS Test prescreens a broad panel of cancer drugs in patient-derived live tumor cells and provides actionable results 70% of the time, on average.

time, actionable results, cancer drugs, broad panel, The PARIS Test, patient-derived live tumor cells